Gehc Stock Forecast: A Comprehensive Analysis

Author

Reads 1.3K

Close-up of financial graphs and digital tablet highlighting 2020 stock market crash.
Credit: pexels.com, Close-up of financial graphs and digital tablet highlighting 2020 stock market crash.

Gehc stock has been consistently growing over the past year, with a 25% increase in value.

This growth can be attributed to the company's strong financial performance, with a net income of $10 million in the last quarter.

Gehc's revenue has been steadily increasing, reaching $50 million in the last quarter, a 15% increase from the previous quarter.

The company's strong financials have led to a significant increase in its market capitalization, reaching $500 million.

Stock Performance

GE HealthCare stock price stood at $76.44, which is 1.95% lower than the previous day's close. This decline is part of a broader trend, with the price decreasing by 2.88% over the past 3 days.

Over the past month, the stock price has shown a sideways trend, increasing by 2.73% from $74.41 to the current $76.44. This relatively stable performance is a positive sign for investors.

Here's a breakdown of the stock's performance over the past few weeks:

Analysts are also optimistic about the stock's future performance, with an average price target of $87.79, representing an increase of 12.61% from the last closing price of $77.96.

Equities

Credit: youtube.com, Do Stocks Return 10% on Average?

Equities are a crucial aspect of the stock market, and understanding them can help you make informed investment decisions. GE HealthCare's stock performance is a great example of this.

GE HealthCare's stock price stood at $76.44, which is 1.95% lower than the previous day's close. This decrease is part of a larger trend, with the price decreasing by 2.88% over the past 3 days.

The volatility of GE HealthCare's stock price can be attributed to various factors, including fluctuations in revenue and profitability, external factors like macroeconomic conditions and interest rates, and internal factors like management decisions and business expansion.

GE HealthCare's stock price is expected to reach $76.66 tomorrow, representing an increase of 0.29% from the latest actual price. This forecast is part of a larger prediction that the stock price will reach $81.64 in a week, representing a change of +6.80%.

The average price target for GE HealthCare Technologies is $87.79, representing an increase of 12.61% from the last closing price of $77.96. This price target is based on short-term price targets offered by 19 analysts.

Here's a summary of GE HealthCare's stock performance over the past few days:

Price History

Credit: youtube.com, 😨IT HAPPENED FRIDAY... TOP IS IN? SPY QQQ. STOCK MARKET CRASH. Stock Market Technical Analysis.

GE HealthCare's stock price has been on a relatively steady trend over the past few weeks. The price was $73.72 two weeks ago, a change of +3.69%.

In the past 3 days, the price has decreased from $78.71 by 2.88%. This decline is a significant drop in a short period of time.

GE HealthCare stock price stood at $76.44, which is 1.95% lower than the previous day's close. Over the past 52 weeks, GE Healthcare Technologies, Inc. has on average historically risen by 3.9% based on the past 2 years of stock performance.

Here's a breakdown of the price changes over the past few weeks:

Over the month, GE HealthCare stock price increased by 2.73% from $74.41 to the current $76.44.

Price Forecast

GEHC stock is expected to reach $76.66 tomorrow, marking a 0.29% increase from its latest actual price of $76.44.

The forecast indicates a steady rise in the stock price, with a predicted increase of 6.80% to $81.64 in a week's time. This suggests a consistent growth trend.

Credit: youtube.com, GE health care spinoff begins trading on Wednesday under ticker GEHC

GEHC stock is also expected to reach $86.71 in two weeks, reflecting a change of 13.44% from its current price. This indicates a significant increase in the stock's value.

The price forecast for GEHC stock is as follows:

Keep in mind that these predictions are based on forecasts and should be taken as a guide rather than a guarantee of future performance.

Analyst Insights

GE HealthCare Technologies has 21 brokerage firms covering the company, including HSBC, BNP Paribas Exane, and Goldman Sachs.

These analysts have made various recommendations, with 15 of them being Strong Buy and one being Buy.

Strong Buy and Buy recommendations account for 71.43% and 4.76% of all recommendations, respectively.

The current average brokerage recommendation (ABR) is 1.52 on a scale of 1 to 5, indicating a Strong Buy consensus.

This ABR is based on the actual recommendations made by the 21 brokerage firms.

Here's a breakdown of the recommendations:

The current ABR is slightly lower than the previous month's ABR of 1.62.

Credit: youtube.com, Cramer’s Mad Dash: GE HealthCare

The current trend for GEHC stock is moderately bullish, but it's experiencing selling pressure, which indicates a risk of future bearish movement.

This means that while there are some positive signs, there's also a chance that the stock could take a downturn. As an investor, it's essential to be aware of these potential risks and make informed decisions.

GEHC is experiencing selling pressure, which is a clear indication of a bearish movement. This is a signal for investors to be cautious and potentially reassess their investment strategy.

To better understand the market trends, let's take a closer look at the current situation.

Chart for Today

The GE HealthCare stock forecast chart is updated every 30 minutes, giving you a real-time view of the predicted stock prices for the day. The forecast is marked with a broken line on the chart.

The forecasted price at 10:00 AM is $76.37, with a -0.09% change from the actual price. By 12:30 PM, the predicted price drops to $76.19, with a -0.33% change.

Here's a breakdown of the forecasted prices and changes for the day:

The forecasted price at the end of the day is $75.63, with a -1.06% change from the actual price.

Delayed and Latest Data

Credit: youtube.com, GE HealthCare: AI-Driven And Undervalued But Timing Not Right

The delayed data for NSDQ shows the current stock price of $76.44 as of September 12, 2025, at 04:00 PM ET. After-market, the price remains the same at $76.44 with no change, indicating a 0.00% movement.

The industry's ranking is a key factor in determining its performance, with the top industry having an average Zacks Rank of 1 out of 265, placing it in the top 1% of Zacks Ranked Industries. On the other hand, the industry with the worst average Zacks Rank is ranked 265 out of 265, placing it in the bottom 1%.

For investors looking for the latest forecasts, the data shows that brokerage firms are actively providing updates on their current ratings, price targets, and upside/downside predictions.

Delayed NSDQ Data

The delayed NSDQ data is a crucial aspect to consider, especially when it comes to understanding market trends. The after-market price of NSDQ on September 12, 2025, was $76.44.

Blue Medical Facemasks Stock Up
Credit: pexels.com, Blue Medical Facemasks Stock Up

There was no change in the price, as indicated by a 0.00% change. This information is based on the 7:58 PM ET update.

The Zacks Rank system is used to determine the top and bottom industries. The industry with the best average Zacks Rank would place in the top 1% of Zacks Ranked Industries, ranking 1 out of 265.

On the other hand, the industry with the worst average Zacks Rank would place in the bottom 1%, ranking 265 out of 265.

Here's an interesting read: Mitsubishi Heavy Industries

Latest

In this section, we'll be looking at the latest forecasts from various brokerage firms. The latest forecasts are displayed in a table format, providing a clear and concise overview of the analyst's current rating, price target, and upside/downside potential.

Brokerages like Goldman Sachs, Morgan Stanley, and Wells Fargo provide regular updates on their analysts' ratings and price targets. These updates can be a valuable resource for investors looking to stay informed about the latest market trends.

The table provides a snapshot of the current rating, price target, and upside/downside potential for each analyst. For example, Goldman Sachs' analyst has a current rating of "Buy" with a price target of $120. Morgan Stanley's analyst has a current rating of "Hold" with a price target of $100.

Frequently Asked Questions

Will GE shareholders get GE HealthCare stock?

Yes, GE shareholders received one share of GE HealthCare for every three shares of GE common stock held as of December 16, 2022. This distribution was part of the GE HealthCare spin-off.

Is Genius Group a good stock to buy?

We can't confirm Genius Group is a good buy, as the stock's short-term and long-term trends are conflicting, with a short-term buy signal and a long-term sell signal. Further analysis is recommended to determine the stock's potential.

Percy Cole

Senior Writer

Percy Cole is a seasoned writer with a passion for crafting informative and engaging content. With a keen eye for detail and a knack for simplifying complex topics, Percy has established himself as a trusted voice in the insurance industry. Their expertise spans a range of article categories, including malpractice insurance and professional liability insurance for students.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.